Skip to content
Search

Latest Stories

Nearly 400,000 turn to urgent care or GP as pharmacies cannot fill their prescriptions

Liberal Democrats calls for urgent action to ensure patients can access the medication they desperately need and to help struggling pharmacies stay open

Nearly 400,000 turn to urgent care or GP as pharmacies cannot fill their prescriptions

Pressures with managing medicines shortages impacting mental health of pharmacy staff

gettyimages

Patients are struggling to access their prescriptions as pharmacies grapple with financial strain and ongoing medicine shortages.

Analysis of the ONS Health Insight Survey by the Liberal Democrats revealed that an estimated 382,000 adults visited their GP or an urgent care service in December alone because their usual pharmacy was unable to fill their NHS prescription.


In addition, a further 269,000 took no further action after they couldn’t get their prescription between 10 December and 1 January.

Overall, an estimated 3 million people—13.5% of those using prescription services—reported experiencing issues with obtaining their medication during this period.

A significant number, 426,000 people, were forced to visit multiple pharmacies to secure their prescription, while 336,000—more than one in ten affected patients—had to wait over a week to resolve their medication issue.

Furthermore, an estimated 853,000 people expressed dissatisfaction with the NHS pharmacy service they had received.

Liberal Democrat Hospitals and Primary Care spokesperson Jess Brown-Fuller MP warned that frontline health services are “at breaking point” with devastating consequences for patients.

“We have heard from countless people who are struggling to access their prescriptions when they need them with many turning to A&E or their GP or even going without the medicine they need to get through their daily lives,” he said.

“All this piles pressure on our hospitals and primary care services that are already at the brink.”

The MP accused the Conservative Party of “shameful neglect” that has punished patients in this way, and condemned the Labour government’s “total lack of urgency” as “inexcusable.”

“It is not good enough for the government to sit back and watch as people can't access the medicines they need,” he said.

He emphasised the need for urgent action to ensure “patients can access the medication they desperately need and struggling pharmacies can keep their doors open.”

The Liberal Democrats pointed to rising medicines purchasing costs as a major factor driving financial pressures for pharmacies, many of which are at risk of closure.

An analysis by the National Pharmacy Association (NPA) found that 87% of council areas have lost at least one pharmacy in the past two years.

Meanwhile, findings from the Royal Pharmaceutical Society’s (RPS) latest Workforce Wellbeing Survey paint a troubling picture of the impact of medicine shortages on pharmacy teams.

More than 6,500 pharmacists and pharmacy technicians took part in the survey, with over 40% believing that medicine shortages have put patients at risk, potentially causing worsening health conditions, flare-ups, relapses, or a reduced quality of life.

In the past 12 months, 56% of respondents reported that pressures with managing medicines shortages had directly impacted their mental health and wellbeing, and 49% said they had experienced verbal abuse due to medicine shortages.

Additional stress factors included inadequate staffing, lack of work-life balance, increased financial pressures, lack of protected learning time, lack of colleague or senior support, and long working hours.

The survey further revealed that 87% of respondents were at high risk of burnout, while only 21% felt their mental health was a priority in the workplace.

“Pharmacy teams want to do everything possible to provide the medicines their patients need, and it’s deeply distressing when they can’t,” said RPS President Professor Claire Anderson.

“This sense of ‘moral injury’ – of knowing what patients need but being unable to deliver it due to circumstances beyond their control – is taking a heavy toll on their wellbeing,” she added.

Professor Anderson stressed the urgent need for solutions, not only for the wellbeing of the workforce but for ensuring safe and effective patient care.

More For You

Mike Hewitson, superintendent pharmacist & managing director of Beaminster Pharmacy

Mike Hewitson elected as NPA board member for England

Mike Hewitson elected as NPA board member for England: New term begins April

Mike Hewitson, superintendent pharmacist & managing director ofBeaminster Pharmacy, has been elected as the next National Pharmacy Association (NPA) board member for England.

Since 2023, Hewitson has served as chair of Community Pharmacy Dorset. He is also a member of Somerset Council and a Non-Executive Director at HubRx.

Keep ReadingShow less
Store closures 2024: Chemists among hardest hit

Over 600 chemist shops belonging to multiples and chains were closed last year

Getty Images

35 shops closed per day last year, chemists worst affected

More shops are expected to exit the UK high streets driven by driven by rising operational costs and a continued shift towards online shopping and transactions.

According to figures from PwC, a total of 12,804 outlets operated by chains (those with five or more locations) exited high streets, shopping centres and retail parks in 2024 – equivalent to 35 closures per day.

Keep ReadingShow less
Empty pharmacy shelves due to UK medicine shortages.

The government has said it's investing up to £520m to manufacture more medicines

Pic credit: iStock

Brexit blamed for UK medicine shortages with "little sign of recovery"

The UK is facing “a worsening situation” with drugs shortages compared to the rest of Europe as a result of Brexit, according to the Nuffield Trust health thinktank.

It comes of the back of data that revealed that the department of health and social care (DHSC) received 1,938 notifications of disruptions to medicine supply last year – the highest in four years.

Keep ReadingShow less
Alert! Patients on Promixin should be switched to alternatives by 30 April

Promixin is licensed for treating chronic pulmonary infections caused by Pseudomonas aeruginosa in adults and children with cystic fibrosis

Getty Images

Medicine shortage: Promixin to be discontinued from May 2025

The Department of Health and Social Care (DHSC) and NHS England have issued a national patient safety alert regarding the upcoming shortage of Promixin (colistimethate).

The alert, issued on 17 March 2025, states that Promixin (colistimethate) 1-million-unit powder for nebuliser solution unit dose vials (UDVs) will be discontinued from early May 2025, with stocks expected to be exhausted by this time.

Keep ReadingShow less
PAGB welcomes new vice-presidents and treasurer to Board

Rob Elliott and Bas Vorsteveld ( L-R)

Bas Vorsteveld will now oversee the Kenvue’s business in Northern Europe

PAGB appoints new vice-presidents and treasurer to Board

PAGB, the consumer healthcare association, has announced the appointment of two new vice-presidents and a treasurer to their Board.

Bas Vorsteveld, area managing director for Northern Europe at Kenvue, and Rob Elliott, OTC centre of excellence lead at Viatris, have been elected as vice-presidents.

Keep ReadingShow less